Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low-dose secondary prophylaxis study.
China
health care
hemarthrosis
hemophilia A
outcome assessment
prophylaxis studies
ultrasonography
Journal
Research and practice in thrombosis and haemostasis
ISSN: 2475-0379
Titre abrégé: Res Pract Thromb Haemost
Pays: United States
ID NLM: 101703775
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
30
12
2020
revised:
23
04
2021
accepted:
29
04
2021
entrez:
27
9
2021
pubmed:
28
9
2021
medline:
28
9
2021
Statut:
epublish
Résumé
In countries with restricted access to clotting factor concentrates, early implementation of low-dose prophylaxis is recommended over episodic treatment. The objective of this 1-year prospective secondary prophylaxis study was to evaluate the efficacy of a dose/frequency escalating protocol in young boys with hemophilia A in China. Boys were started on a low-dose protocol (minimum 10-15 IU/kg of factor VIII [FVIII] twice weekly). Escalation was based on index joint bleeding, swelling/persistent joint swelling, and serial ultrasound (gray scale and color Doppler) examinations of index joints. Thirty-three boys, median age 4.8 years (interquartile range, 3.8-6.1) were enrolled in a 3-month observation period that preceded a 1-year prophylaxis phase. A significant reduction in total bleeding events (43.0%, A low-dose, individualized prophylaxis protocol, guided by individual bleeding profiles and serial assessment of joint status, enables escalation of treatment intensity in boys with severe hemophilia A, leading to a significant reduction in bleeding events and reduction in target joint bleeding.
Identifiants
pubmed: 34568725
doi: 10.1002/rth2.12552
pii: S2475-0379(22)01436-4
pmc: PMC8449287
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e12552Informations de copyright
© 2021 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH).
Références
J Pediatr. 2004 Nov;145(5):628-34
pubmed: 15520762
Blood Coagul Fibrinolysis. 2017 Sep;28(6):425-430
pubmed: 27898515
Haemophilia. 2020 Aug;26 Suppl 6:1-158
pubmed: 32744769
N Engl J Med. 2007 Aug 9;357(6):535-44
pubmed: 17687129
Haemophilia. 2013 Jan;19(1):27-34
pubmed: 23231016
Expert Rev Hematol. 2017 Nov;10(11):995-1004
pubmed: 28971697
Haemophilia. 2011 Jan;17(1):70-4
pubmed: 20579111
Haemophilia. 2016 May;22(3):331-3
pubmed: 26612614
Blood Rev. 2018 Jul;32(4):265-271
pubmed: 29426727
Haemophilia. 2006 Sep;12(5):518-25
pubmed: 16919083
Haemophilia. 2007 May;13(3):293-304
pubmed: 17498079
Haemophilia. 2016 May;22(3):342-8
pubmed: 26987935
Arthritis Rheum. 2009 Sep 15;61(9):1194-201
pubmed: 19714611
Southeast Asian J Trop Med Public Health. 1995 Jun;26(2):243-6
pubmed: 8629053
Blood. 2013 Aug 15;122(7):1129-36
pubmed: 23777770
J Intern Med. 1992 Jul;232(1):25-32
pubmed: 1640190
Clin Orthop Relat Res. 1980 Jun;(149):153-9
pubmed: 7408294
Haemophilia. 2017 Jan;23(1):77-81
pubmed: 27943510
Thromb Haemost. 1995 Feb;73(2):247-51
pubmed: 7792738
Arthritis Care Res (Hoboken). 2011 Feb;63(2):223-30
pubmed: 20862683
Haemophilia. 2016 Jul;22(4):514-20
pubmed: 26930418
Haemophilia. 2014 May;20(3):e227-30
pubmed: 24589184
Blood. 2019 Dec 12;134(24):2127-2138
pubmed: 31697801
Haemophilia. 2009 Sep;15(5):1168-71
pubmed: 19493019
J Thromb Haemost. 2012 Dec;10(12):2494-502
pubmed: 23067060
J Thromb Haemost. 2014 Nov;12(11):1935-9
pubmed: 25059285
Haemophilia. 2021 Jan;27(1):33-40
pubmed: 33245818
AJR Am J Roentgenol. 2015 Mar;204(3):W336-47
pubmed: 25714320
Lancet Haematol. 2019 Jun;6(6):e295-e305
pubmed: 31003963
Lancet Haematol. 2018 Jun;5(6):e252-e260
pubmed: 29731369
Haemophilia. 2019 Jul;25(4):633-639
pubmed: 31044491